Emergent coronary artery bypass grafting x4 on intra-     aortic balloon pump of the left internal mammary artery     to left anterior descending coronary; reverse saphenous     vein single graft from aorta to the first diagonal     coronary; reverse saphenous vein single graft from aorta     to first obtuse marginal coronary; as well as reverse     saphenous vein single graft from aorta to posterior     descending coronary artery.
3. status post percutaneous tracheostomy with #8 Portex/PEG placement on [**2129-6-17**]   History of Present Illness: Jaw and right shoulder pain developed at rest [**6-3**] night,resolving after few minutes.Recurrent pain right shoulder yesterday prompting trip to [**Hospital 9464**] Hospital where troponins were positive (8.4).
Past Medical History: fatty liver DM  Social History: Occupation:computer tech analyst Tobacco:denies ETOH:social   Family History: negative   Physical Exam: Pulse: Resp:18  O2 sat: 99 on 4 L B/P  Right:80/50    Left:82/50 Height:70"     Weight:220#  General:WDWN in NAD> c/o [**1-2**] rt shoulder pain Skin: Dry [x] intact []macular rash w/scabs from itching dorsum hands HEENT: PERRLA [x] EOMI [x] Neck:  Supple [x] Full ROM [x] Chest: Lungs clear bilaterally [x] Heart: RRR [x]  Irregular []  Murmur n Abdomen: Soft [x] non-distended [x] non-tender [x]  bowel sounds + [x] Extremities: Warm [x], well-perfused [x]  Edema Varicosities: None [x] Neuro: Grossly intact Pulses: Femoral      Right:2   Left:2 DP           Right:2   Left:2 PT           [**Name (NI) 167**]:2   Left:2 Radial       Right:2   Left:2  Carotid Bruit        Right:n    Left:n   Pertinent Results: [**2129-6-22**] 02:02AM BLOOD WBC-13.2* RBC-3.80* Hgb-10.8* Hct-32.0* MCV-84 MCH-28.4 MCHC-33.7 RDW-14.0 Plt Ct-420 [**2129-6-21**] 02:45AM BLOOD WBC-10.1 RBC-3.94* Hgb-11.2* Hct-32.7* MCV-83 MCH-28.4 MCHC-34.2 RDW-14.1 Plt Ct-373 [**2129-6-22**] 02:02AM BLOOD PT-23.1* PTT-49.1* INR(PT)-2.2* [**2129-6-21**] 02:45AM BLOOD PT-18.4* PTT-57.3* INR(PT)-1.7* [**2129-6-20**] 01:21AM BLOOD PT-16.9* PTT-63.6* INR(PT)-1.5* [**2129-6-19**] 08:09AM BLOOD PT-15.2* PTT-62.9* INR(PT)-1.3* [**2129-6-19**] 02:03AM BLOOD PT-14.9* PTT-63.6* INR(PT)-1.3* [**2129-6-18**] 08:04PM BLOOD PT-13.8* PTT-60.1* INR(PT)-1.2* [**2129-6-22**] 02:02AM BLOOD Glucose-189* UreaN-24* Creat-0.7 Na-137 K-3.8 Cl-95* HCO3-31 AnGap-15 [**2129-6-21**] 02:45AM BLOOD Glucose-194* UreaN-18 Creat-0.7 Na-133 K-3.6 Cl-94* HCO3-30 AnGap-13 [**2129-6-20**] 01:21AM BLOOD Glucose-201* UreaN-15 Creat-0.7 Na-135 K-3.7 Cl-97 HCO3-27 AnGap-15  Left ventricular wall thicknesses and cavity size are normal.
Brief Hospital Course: The patient arrived on a heparin drip and IABP.
Overall the patient tolerated the procedure well and post-operatively was transferred to the CVICU in critical but stable condition requiring milrinone and  epinephrine to optimize his cardiac function.
Vancomycin was used for surgical antibiotic prophylaxis, given his inpatient preoperative stay of greater than 24 hours.
Heparin drip was initiated.
Heme recommended systemic anti-coagulation for [**2-26**] months and did not recommend familial/genetic hypercoagulable workup at this time.
Vancomycin and Cefepime were initiated for turbid pericardial fluid/fever/leukocytosis.
Cefepime was continued for GNR in the sputum.
However, his secretions worsened and on [**6-15**] he required reintubation for airway protection /bronchial hygiene management prior to repeating a Head CT scan.
Ultimately due to his difficulty with secretion clearance, Mr.[**Known lastname **] [**Last Name (Titles) 1834**] a percutaneous tracheostomy and PEG placement on [**6-17**].
Tube feedings were resumed.
His secretions did somewhat improve and all antibiotics were discontinued as infection was no longer an issue.
Acetaminophen 325 mg Tablet Sig: Two (2) Tablet PO Q4H (every 4 hours) as needed for temperature >38.0.
Aspirin 81 mg Tablet, Chewable Sig: One (1) Tablet, Chewable PO DAILY (Daily).
Nystatin 100,000 unit/mL Suspension Sig: Five (5) ML PO QID (4 times a day).
Simvastatin 10 mg Tablet Sig: Two (2) Tablet PO DAILY (Daily).
Warfarin 1 mg Tablet Sig: MD to dose Tablet PO DAILY (Daily): PAF/Thromboembolic event, INR goal 2-3.0.
Scopolamine Base 1.5 mg Patch 72 hr Sig: One (1) Patch 72 hr Transdermal DAILY (Daily).
Carvedilol 3.125 mg Tablet Sig: One (1) Tablet PO BID (2 times a day).
Olanzapine 2.5 mg Tablet Sig: One (1) Tablet PO HS (at bedtime) as needed for aggitation.
Furosemide 40 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Warfarin 2.5 mg Tablet Sig: One (1) Tablet PO ONCE (Once) for 1 doses: *given.
Bisacodyl 10 mg Suppository Sig: One (1) Suppository Rectal HS (at bedtime) as needed for constipation.
Albuterol Sulfate 90 mcg/Actuation HFA Aerosol Inhaler Sig: Four (4) Puff Inhalation Q6H (every 6 hours).
Ipratropium Bromide 17 mcg/Actuation HFA Aerosol Inhaler Sig: Two (2) Puff Inhalation Q6H (every 6 hours).
Chlorhexidine Gluconate 0.12 % Mouthwash Sig: One (1) ML Mucous membrane [**Hospital1 **] (2 times a day).
Amiodarone 200 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Tamsulosin 0.4 mg Capsule, Sust.
Potassium Chloride 20 mEq / 50 ml SW IV PRN K<4.4 and CR<2.0  ** Concentrated KCL must be given via central line only ** 21.
Insulin Regular Human 100 unit/mL (3 mL) Insulin Pen Sig: One (1)  Subcutaneous every six (6) hours: per SS protocol.
Lantus 100 unit/mL Cartridge Sig: As directed  Subcutaneous twice a day.
Heparin Flush (10 units/ml) 2 mL IV PRN line flush PICC, heparin dependent: Flush with 10mL Normal Saline followed by Heparin as above daily and PRN per lumen.
Acute myocardial infarction refractory to all medical     therapy including intra-aortic balloon pump.
